Advanced MedTech makes strategic investments in category disruptive technologies in the healthcare sector.
To date, Advanced MedTech has made 10 M&A strategic transactions.
Leveraging a strong track record in taking medical innovations from development through to regulatory
approvals and commercialisation, we invest in high-growth, well-run healthcare technology companies.
Recent M&A Transactions:
Unlocking the Future of Dialysis
Advent Access is a medical technology startup in end stage renal disease management. Founded based on Stanford Biodesign principles and as a spin-off from A*STAR, Advent Access' first product is the av-Guardian™, a device that improves vascular access reliability, reduces cannulation pain and in the long run, preserves the health of an arteriovenous fistula. The av-Guardian™ forms a key component of Advent Access' dialysis-machine agnostic platform to empower patients to perform hemodialysis independently, safely and more affordably.
Changing Dialysis Forever
AWAK Technologies is a medical technology company, founded in 2007 that is dedicated to transforming the lives of patients suffering from kidney disease. The company has developed a patented sorbent technology which revolutionizes dialysis by reducing the amount of dialysate required. This technology enables the development of light-weight, compact, automated wearable and portable medical devices.